Neuroendocrine Tumor Research Foundation

A New Pace for Progress: 2017

2017 sets new record for research funding

$5.2 million in new research grants	9 new research projects
15 active projects	30 funded scientists
$3.6 million granted in Accelerator Awards for transformational NET research

Partnering with foremost authorities
in the search for answers

Funding research at top cancer centers in institutions worldwide

U.S.A. grantees include: Dana-Farber Cancer Center; MD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; and Stanford University

International grantees include: Genome Sciences Centre, Canada; Hubrecht Institute, Netherlands; and University College London Cancer Institute, UK

Gathering over 100 thought leaders in NET research for annual collaborative research symposium

Strategically recruiting new talent to the field

More than 30% of active researchers are new to NET research

Laura Banaszynski, PhD University of Texas, Southwestern Medical Center	Sharon Gorski, PhD Genome Sciences Centre, Canada
Hans Clevers, MD, PhD Hubrecht Institute, Netherlands	Brian Untch, MD Memorial Sloan Kettering Cancer Center

• Double the number of researchers requested funding in 2017 compared to 2016

• 30% of requests for funding came from researchers new to NET research

Empowering and Educating Patients

Meeting patient needs for NETs info
about treatment options and providers

Four patient and caregiver conferences, including our first Midwest Conference

Record setting outreach for World NET Cancer Day by collaborating with international patient support and advocacy groups

600 attendees	27 new patient videos posted
5,000+ followers	2,000+ followers
First international patient/provider summit	Close to 2,500 searches of NETRF’s doctor database

Raising Hope and Possibility

1,400+ donors	1,500+ gifts
5 events in support of NETRF
Given 4-Star Rating for 3rd consecutive year by Charity Navigator	Guidestar Exchange Gold Recognition and Top Rated by greatnonprofits.org

Building Passion and Purpose

Saluting the many patient leaders in the NET community

Honoring the many patients, advocates, and leaders we lost in 2017, who helped raise awareness of NETs

Wishing Ron Hollander
a fond farewell

All Made Possible with Your Support

Welcoming new Chief Executive Officer Elyse Gellerman, MHS

Applauding the dedication of NET Research Foundation’s Board of Directors, Board of Scientific Advisors, Staff, external reviewers, and event speakers.

Thanking all who shared their proposals for advancing NETs in their research grant applications.

Thank You

DONATE

The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for carcinoid, pancreatic, and related neuroendocrine cancers.

NETRF is a 501(c)(3) organization. All contributions are tax-deductible to the extent allowed by law. To learn more,
view our Audited Financial Statements and IRS Form 990.

Share this email

Manage your preferences | Opt out using TrueRemove®
Got this as a forward? Sign up to receive our future emails.
View this email online.

321 Columbus Avenue, Suite 5R
Boston, MA | 02116 US

This email was sent to .
Continue receiving our emails, add us to your address book.